Role of leptin in energy homeostasis in humans

Journal of Endocrinology

Volumn 223, Issue 1, 2014, Pages T83-T96

  Rosenbaum, Michael ^a   Leibel, Rudolph L ^a  

^a Division of Molecular Genetics Departments of Pediatrics and Medicine College of Physicians and Surgeons Columbia University Russ Berrie Medical Science Pavilion ^*  (United States)

Author keywords

Energy; Leptin; Metabolism; Obesity

Indexed keywords

LEPTIN;

ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CHOLINERGIC SYSTEM; DIET RESTRICTION; ENERGY BALANCE; HOMEOSTASIS AND REGULATION; HUMAN; HUNGER; LEPTIN DEFICIENCY; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION; WEIGHT CONTROL; WEIGHT REDUCTION; BIOLOGICAL MODEL; BLOOD; DRUG EFFECTS; ENERGY METABOLISM; HOMEOSTASIS; OBESITY; PATHOPHYSIOLOGY;

BODY WEIGHT; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LEPTIN; MODELS, BIOLOGICAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 84907882182     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0358     Document Type: Article

References (114)

1. Ahima R, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier J 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382 250-252. (doi:10.1038/382250a0)
2. Ahima R, Kelly J, Elmquist J & Flier J 1999 Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140 4923-4931. (doi:10.1210/endo.140.11.7105)
3. Ahima R, Saper C, Flier J & Elmquist J 2000 Leptin regulation of neuroendocrine systems. Frontiers in Neuroendocrinology 21 263-207. (doi:10.1006/frne.2000.0197)
4. Anand B & Brobeck J 1951 Hypothalamic control of food intake in rats and cats. Yale Journal of Biology and Medicine 24 123-140.
5. Baldwin K, Joanisse D, Haddad F, Goldsmith R, Gallagher D, Pavlovich K, Shamoon E, Leibel R & Rosenbaum M 2011 Effects of weight loss and leptin on skeletal muscle in human subjects. American Journal of Physiology. Endocrinology and Metabolism 301 R1259-R1266. (doi:10.1152/ajpregu.00397.2011)
6. Barash I, Cheung C, Weigle D, Ren H, Kramer J, Fallon M, Kabigting E, Kujiper J, Clifton D & Steiner R 1996 Leptin is a metabolic signal to the reproductive system. Endocrinology 137 3144-3147. (doi:10.1210/endo.137.7.8770941)
7. Boozer C, Love R, Cha M, Leibel R & Aronne L 2001 Synergy of leptin and sibutramine in treatment of diet-induced obesity in rats. Metabolism 50 889-893. (doi:10.1053/meta.2001.24917)
8. Brinkoetter M, Magkos F, Vamviini M & Mantzoros C 2011 Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women. American Journal of Physiology. Endocrinology and Metabolism 301 E99-104. (doi:10.1152/ajpendo.00146.2011)
9. Canepari M, Cappelli V, Pellegrino M, Zanardi M & Reggiani C 1998 Thyroid hormone regulation of MHC isoform composition and myofibrillar ATPase activity in rat skeletal muscles. Archives of Physiology and Biochemistry 106 308-315. (doi:10.1076/apab.106.4.308.4373)
10. Chan J, Matarese G, Shetty G, Raciti P, Klesidis I, Aufiero D, De Rosa V, Perna F, Fontana S & Mantozoros C 2006 Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. PNAS 103 8481-8486. (doi:10.1073/pnas.0505429103)
11. Chan J, Wong S & Mantzoros C 2008 Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity. Clinical Pharmacokinetics 47 753-764. (doi:10.2165/00003088-200847110-00006)
12. Chiba T, Komatsu T, Nakayama M, Adachi T, Tamashiro Y, Hayashi H, Yamaza H, Higami Y & Shmokawa I 2009 Similar metabolic response to calorie restriction in lean and obese Zucker rats. Molecular and Cellular Endocrinology 309 17-25. (doi:10.1016/j.mce.2009.05.001)
13. Chou S, Chamberland J, Liu X, Matarese G, Gao C, Stefanakis R, Brinkoetter M, Gong H, Arampatzi K & Mantzoros C 2011 Leptin is an effective treatment for hypothalamic amenorrhea. PNAS 108 6585-6590. (doi:10.1073/pnas.1015674108)
14. Civitarese A, Smith S & Ravussin E 2007 Diet, energy expenditure, and mitochondrial biogenesis. Current Opinion in Clinical Nutrition and Metabolic Care 10 679-687. (doi:10.1097/MCO.0b013e3282f0ecd2)
15. Coleman D 1973 Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9 294-298. (doi:10.1007/BF01221857)
16. Coleman D 1978 Obesity and diabetes: two mutant genes causing diabetesobesity syndromes in mice. Diabetologia 14 141-148. (doi:10.1007/BF00429772)
17. Conroy R, Girotra M, Shane E, McMahon C, Pavlovich K, Leibel R, Rosenbaum M & Korner J 2011 Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism 60 1222-1226.
18. DelParigi A, Chen K, Salbe A, Hill J, Wing R, Reiman E & Tataranni P 2004 Persistence of abnormal neural response to a meal in postobese individuals. International Journal of Obesity 28 370-307. (doi:10.1038/sj.ijo.0802558)
19. Farooqi I, Jebb S, Langmack G, Lawrence E, Cheetham C, Prentice A, Hughes I, McCamish M & O'Rahilly S 1999 Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 341 879-884. (doi:10.1056/NEJM199909163411204)
20. Farooqi I, Matarese G, Lord G, Keogh J, Lawrence E, Agwu C, Sanna V, Jebb S, Perna F, Fontana S et al. 2002 Beneficial effects of leptin on obesity. T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110 1093-1103. (doi:10.1172/JCI0215693)
21. Farooqi I, Keogh J, Yeo G, Lank E, Ceetham T & O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England Journal of Medicine 348 1085-1095. (doi:10.1056/NEJMoa022050)
22. Flier J 1998 Clinical review 94: what's in a name? In search of leptin's physiologic role Journal of Clinical Endocrinology and Metabolism 83 1407-1413. (doi:10.1210/jcem.83.5.4779)
23. Fogteloo A, Pijl H, Frolich M, McCamish M & Meinders A 2003 Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutrition & Metabolism 16 109-114.
24. Fontana L, Klein S, Holloszy J & Premachandra B 2006 Effect of long-term caloric restriction with adequate protein and micronutrients on thyroid hormones. Journal of Clinical Endocrinology and Metabolism 91 3232-3235.
25. Foster G, Wyatt H, Hill J, Makris A, Rosenbaum D, Brill C, Stein R, Mohammed B, Miller B, Rader D et al. 2010 Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Annals of Internal Medicine 153 147-157. (doi:10.7326/0003-4819-153-3-201008030-00005)
26. Franz M, VanWormer J, Crain A, Boucher J, Histon R, Caplan W, Bowman J & Pronk N 2007 Weight-loss outcomes: a systematic review and metaanalysis of weight-loss clinical trials with minimum 1-year follow-up. Journal of the American Diabetic Association 107 1755-1767. (doi:10.1016/j.jada.2007.07.017)
27. Friedman J & Halaas J 1998 Leptin and the regulation of body weight in mammals. Nature 395 763-770. (doi:10.1038/27376)
28. Frisch R 1980 Delayed menarche and amenorrhea in ballet dancers. New England Journal of Medicine 303 17-19. (doi:10.1056/NEJM198007033030105)
29. Goldsmith R, Joanisse D, Gallagher D, Pavlovich K, Shamoon E, Leibel R & Rosenbaum M 2010 Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. American Journal of Physiology 298 R79-R88. (doi:10.1152/ajpregu.00053.2009)
30. Halaas J, Gajiwala K, Maffei M, Cohen S, Chait B, Rabinowitz D, Lallone R, Burley S & Friedman J 1995 Weight reducing effects of the plasma protein encoded by the ob gene. Science 269 543-546. (doi:10.1126/science.7624777)
31. Halaas J, Boozer C, Blair-West J, Fidahusein N, Denton D & Friedman J 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. PNAS 94 8878-8883. (doi:10.1073/pnas.94.16.8878)
32. Hetherington A & Ranson S 1940 Hypothalamic lesions and adiposity in the rat. Anatomical Record 78 149-172. (doi:10.1002/ar.1090780203)
33. Hetherington A & Ranson S 1942 The spontaneous activity and food intake of rats with hypothalamic lesions. American Journal of Physiology 136 609-617.
34. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P et al. 1999 Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Journal of the American Medical Association 292 1568-1575. (doi:10.1001/jama.282.16.1568)
35. Hinkle W, Cordell M, Leibel R, Rosenbaum M & Hirsch J 2013 Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans. PLoS ONE 8 e59114. (doi:10.1371/journal.pone.0059114)
36. Hukshorn C, Saris CHW, Westerterp-Plantenga M, Farid A, Smith F & Campfield L 2000Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. Journal of Clinical Endocrinology and Metabolism 85 4003-4009.
37. Hukshorn CJ, van Dielen FM, Berman WA, Westerp-Plantenga MS, Campfield LA & Saris WH 2002 The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. International Journal of Obesity 26 504-509.
38. Hukshorn C, Westerterp-Plantenga M & Saris W 2003 Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted overweight men. American Journal of Clinical Nutrition 77 771-776.
39. Javor E, Cochran E, Musso C, Young J, Depaoli A & Gorden P 2005 Longterm efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54 1994-2002.
40. Johansson K, Neovius M & Hemingsson E 2014 Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 99 14-23. (doi:10.3945/ajcn.113.070052)
41. Kaira S 2001 Circumventing leptin resistance for weight control. PNAS 98 4279-4281. (doi:10.1073/pnas.091101498)
42. Kardos A, Taylor D, Thompson C, Styles P, Hands L, Collin J & Casadei B 2000 Sympathetic denervation of the upper limb improves forearm exercise performance and skeletal muscle bioenergetics. Circulation 13 2716-2720. (doi:10.1161/01.CIR.101.23.2716)
43. Keesey R & Corbett S 1984 Metabolic defense of the body weight set-point. Research Publications - Association for Research in Nervous and Mental Disease 62 87-96.
44. Kennedy G 1953 The role of depot fat in the hypothalamic control of food intake in the rat. Proceedings of the Royal Society of London, Series B: Biological Sciences 140 578-592. (doi:10.1098/rspb.1953.0009)
45. Kissileff H, Thornton M, Torres M, Pavlovich K, Leibel R & Rosenbaum M 2012 Maintenance of reduced body weight in humans is associated with leptin-reversible declines in satiation. American Journal of Clinical Nutrition 95 309-317. (doi:10.3945/ajcn.111.012385)
46. Korner J & Aronne L 2003 The emerging science of body weight regulation and its impact on obesity treatment. Journal of Clinical Investigation 111 565-570. (doi:10.1172/JCI17953)
47. Korner J, Chua S, WIlliams J, Leibel R & Wardlaw S 1999 Regulation of hypothalamic pro-opiomalanocortin by lean and obese rats. Neuroendocrinology 70 377-383. (doi:10.1159/000054499)
48. Korner J, Savontaus E, Chua S, Leibel R & Wardlaw S 2001 Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. Journal of Neuroendocrinology 13 959-966. (doi:10.1046/j.1365-2826.2001.00716.x)
49. Korner J, Conroy R, Febres G, McMahon D, Cornwell I, Karmally W & Aronne L 2013 Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity 21 951-956. (doi:10.1002/oby.20433)
50. Lee J, Reed D & Price R 2001 Leptin resistance is associated with extreme obesity and aggregates in families. International Journal of Obesity 25 1471-1473. (doi:10.1038/sj.ijo.0801736)
51. Lee J, Chan J, Sourlas E, Raptopoulos V & Mantzoros C 2006 Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. Journal of Clinical Endocrinology and Metabolism 91 2605-2611.
52. Legradi G, Emerson C, Ahima R, Flier J & Lechan R 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138 2596-2576. (doi:10.1210/endo.138.6.5209)
53. Lehmann A, Bauer U, Jhorth S, Rosenbaum M & Leibel R 2014 Emerging pharmacological approaches to the management of obesity through appetite suppression. In Neuroendocrinology of Appetite, International Neuroscience Federation Master Class Series. Eds S Dickson & J Mercer. Gothenberg, Sweden.
54. Leibel R 1990 Is obesity due to a heritable difference in "set-point" for adiposity? Western Journal of Medicine 153 429-431.
55. Leibel R & Hirsch J 1984 Diminished energy requirements in reduced-obese patients. Metabolism 33 164-170. (doi:10.1016/0026-0495(84)90130-6)
56. Leibel R & Rosenbaum M 2010 Metabolic response to weight perturbation. In Novel Insights into Adipose Cell Functions, Research and Perspectives in Endocrine Interactions, pp 121-133. Ed K Clément. Heidelberg, Germany: Springer-Verlag.
57. Leibel RL, Bahary N & Friedman JM 1990 Genetic variation and nutrition in obesity: approaches to the molecular genetics of obesity. In Genetic Variation and Nutrition, pp 90-101. Eds AP Simopoulos & B Childs. World Review of Nutrition and Dietetics series. Basel, Switzerland: Karger.
58. Leibel RL, Bahary N & Friedman JM 1993 Strategies for the molecular genetic analysis of obesity in humans. Critical Reviews in Food Science and Nutrition 33 351-358. (doi:10.1080/10408399309527632)
59. Leibel R, Rosenbaum M & Hirsch J 1995 Changes in energy expenditure resulting from altered body weight. New England Journal of Medicine 332 621-628.
60. Lejeune M, Hukshorn C, Saris W & Westerterp-Plantenga M 2003 Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men. International Journal of Obesity 27 1494-1499. (doi:10.1038/sj.ijo.0802431)
61. Lev-Ran A 1974 Secondary amenorrhea resulting from uncontrolled weight reduction diets. Fertility and Sterility 25 459-462.
62. Li X & Larsson L 1997 Contractility and myosin isoform compositions of skeletal muscles and muscle cells from rats treated with thyroid hormone for 0, 4 and 8 weeks. Journal of Muscle Research and Cell Motility 18 335-344. (doi:10.1023/A:1018674126229)
63. Look AHEAD Research Group 2007 Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 30 1374-1383. (doi:10.2337/dc07-0048)
64. Mackintosh R & Hirsch J 2001 The effects of leptin administration in nonobese human subjects. Obesity Research 9 462-469.
65. Mantzoros C, Magkos F, Brinkoetter M, Sienkiewica E, Dardeno T, Hamnvik O & Koniaris A 2011 Leptin in human physiology and pathophysiology. American Journal of Physiology. Endocrinology and Metabolism 301 E567-E584. (doi:10.1152/ajpendo.00315.2011)
66. Martin C, Heilbronn L, de Jonge L, DeLany J, Volaufova J, Anton S, Redman L, Smith S & Ravussin E 2007 Effect of calorie restrictiononrestingmetabolic rate and spontaneous physical activity. Obesity 15 2964-2973.
67. Mayer J 1955 Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis. Annals of the New York Academy of Sciences 63 15-43. (doi:10.1111/j.1749-6632.1955.tb36543.x)
68. McGuire M, Wing R, Klem M & Hill J 1999 Behavioral strategies of individuals who have maintained long-term weight losses. Obesity Research 7 334-341. (doi:10.1002/j.1550-8528.1999.tb00416.x)
69. Mittendorfer B, Horowitz J, DePaoli A, McCamish M, Patterson B & Klein S 2011 Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes. Diabetes 60 1474-1477. (doi:10.2337/db10-1302)
70. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Swewter CP, Digby JE, Mohammed SN, Hurst JA et al. 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 903-908. (doi:10.1038/43185)
71. Moon H, Matarese G, Brennan A, Chamberland J, Liu X, Fiorenza C, Mylvaganam G, Abanni L, Carbone F, Williams C et al. 2011 Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes 60 1647-1656. (doi:10.2337/db10-1791)
72. Morrison C 2009 Leptin resistance and the response to positive energy balance. Physiology & Behavior 94 660-663. (doi:10.1016/j.physbeh.2008.04.009)
73. Myers MG Jr, Cowley M & Munzberg H 2008 Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 70 537-556. (doi:10.1146/annurev.physiol.70.113006.100707)
74. Myers MG Jr, Leibel R, Seeley R & Schwartz M 2010 Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology and Metabolism 21 643-651. (doi:10.1016/j.tem.2010.08.002)
75. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N et al. 1999 Increased glucose metabolism and insulin sensitivity transgenic skinny mice overexpressing leptin. Diabetes 48 1822-1829. (doi:10.2337/diabetes.48.9.1822)
76. Ozata M, Ozdemir I & Licinio J 1999 Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. Journal of Clinical Endocrinology and Metabolism 84 3686-3695. (doi:10.1210/jcem.84.10.5999)
77. Phelan S, Hassenstab J, McCaffery J, Sweet L, Raynor H, Cohen R & Wing R 2011 Cognitive interference from food cues in weight loss maintainers, normal weight, and obese individuals. Obesity 19 69-73. (doi:10.1038/oby.2010.138)
78. Ravussin E, Burnand B, Schutz Y & Jequier E 1982 Twenty-four hour energy expenditure and resting metabolic rate in obese, moderately obese, and control subjects. American Journal of Clinical Nutrition 35 566-573.
79. Ravussin E, Burnand B & Schutz Y 1985 Energy expenditure before and during energy restriction in obese patients. American Journal of Clinical Nutrition 41 753-759.
80. Ravussin E, Smith S, Mitchell J, Shringarpure R, Shan K, Maier H, Koda J & Weyer C 2009 Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity 17 1736-1743. (doi:10.1038/oby.2009.184)
81. Ravussin Y, Gutman R, Diano S, Shanabrough M, Borok E, Sarman B, Lehmann A, Leduc C, Rosenbaum M, Horvath T et al. 2011 Effects of chronic weight perturbation on energy homeostasis and brain structure in mice. American Journal of Physiology. Endocrinology and Metabolism 300 R1352-R1362. (doi:10.1152/ajpregu.00429.2010)
82. Ravussin Y, LeDuc C, Watanabe K, Mueller B, Skowronski A, Rosenbaum M & Leibel R 2014 Effects of chronic leptin infusion on subsequent body weight and composition in male mice: can body weight set-point be reset? Molecular Metabolism 3 432-440. (doi:10.1016/j.molmet.2014.02.003)
83. Redman L, Heilbronn L, Martin C, de Jonge L, Williamson D, Delany J, Ravussin E & Pennington CALERIE Team 2009 Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One 4 e4377. (doi:10.1371/journal.pone.0004377)
84. Rosenbaum M & Leibel R 1998 Leptin: a molecule integrating somatic energy stores, energy expenditure, and fertility. Trends in Endocrinology and Metabolism 9 117-123. (doi:10.1016/S1043-2760(98)00028-9)
85. Rosenbaum M & Leibel R 1999 The role of leptin in human physiology. New England Journal of Medicine 341 913-915. (doi:10.1056/NEJM199909163411211)
86. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F & Leibel R 1997 Effects of weight change on plasma leptin concentrations and energy expenditure. Journal of Clinical Endocrinology and Metabolism 82 3647-3654. (doi:10.1210/jcem.82.11.4390)
87. Rosenbaum M, Vandenborne K, Goldsmith R, Simoneau J, Heymsfield S, Joanisse D, Hirsch J, Murphy E, Matthews D, Segal K et al. 2003 Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. American Journal of Physiology. Endocrinology and Metabolism 285 R183-R192. (doi:10.1152/ajpregu.00474.2002)
88. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E & Leibel R 2005 Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. Journal of Clinical Investigation 115 3579-3586. (doi:10.1172/JCI25977)
89. Rosenbaum M, Hirsch J, Gallagher D & Leibel R 2008a Long-termpersistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. American Journal of Clinical Nutrition 88 906-912.
90. Rosenbaum M, Sy M, Pavlovich K, Leibel R & Hirsch J 2008b Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. Journal of Clinical Investigation 118 2583-2591. (doi:10.1172/JCI35055)
91. Ryan D, Johnson W, Nyers V, Prather T, McGlone M, Rood J, Brantley P, Bray G, Gupta A, Brousard A et al. 2010 Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Archives of Internal Medicine 170 146-154. (doi:10.1001/archinternmed.2009.508)
92. Saris CHW, Westerterp-Plantenga M, Farid A, Smith F & Campfield L 2000 Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. Journal of Clinical Endocrinology and Metabolism 85 4003-4009.
93. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M, Hayase M, Yoshimasa Y et al. 1997 Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138 947-954. (doi:10.1210/endo.138.3.4989)
94. Scarpace P & Zhang Y 2007 Elevated leptin: consequence or cause of obesity. Frontiers in Bioscience 12 3531-3544. (doi:10.2741/2332)
95. Schwartz M, Woods S, Porte D, Seeley R & Baskin D 2000 Central nervous system control of food intake. Nature 404 661-670. (doi:10.1038/35007534)
96. Shetty G, Matarese G, Magkos F, Moon H, Brennan A, Mylvganam G, Sykoutri D, Depaoli A & Mantzoros C 2011 Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet. European Journal of Endocrinology 165 249-254. (doi:10.1530/EJE-11-0252)
97. Sienkiewicz E, Magkos F, Aronis K, Brinkoetter M, Chamberland J, Chou S, Arampatzi K, Gao C, Koniaris A & Mantozoros C 2011 Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 60 1211-1221. (doi:10.1016/j.metabol.2011.05.016)
98. Siklova-Vitkova M, Klimcakova E, Polak J, Kovacova Z, Tencerova M, Rossmeislove L, Bajzova M, Langin D & Stich V 2012 Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women. Journal of Clinical Endocrinology and Metabolism 97 E1176-E1182. (doi:10.1210/jc.2011-2380)
99. Simonides W, Thelon M, VanderLinden C, Larsen P & Hardeveld C 2001 Mechanism of thyroid-hormone regulated expression of SERCA genes in skeletal muscle: implications for thermogenesis. Bioscience Reports 90 139-154. (doi:10.1023/A:1013692023449)
100. Sjostrom L 2013 Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. Journal of Internal Medicine 273 219-234. (doi:10.1111/joim.12012)
101. Skowronski A, Morabito M, Mueller B, Lee S, Hjorth S, Lehmann A, Watanabe K, Zeltser L, Ravussin Y, Rosenbaum M et al. 2014 Effects of a novel MC4R agonist on maintenance of reduced body weight in dietinduced obese mice. Obesity 22 1287-1295. (doi:10.1002/oby.20678)
102. Speakman J, Levitsky D, Allison D, Bray M, de Castro J, Clegg D, Clapman J, Dulloo A, Gruer L, Haw S et al. 2011 Set points, settling points, and some alternative models: theoretic options to understand how genes and environments comebine to regulate body adiposity. Disease Models & Mechanisms 4 733-745. (doi:10.1242/dmm.008698)
103. Sumithran P, Prendergast L, Delbridge E, Purcell K, Shulkes A, Kriketos A & Proietto J 2011 Long-term persistance of hormonal adaptations to weight loss. New England Journal of Medicine 365 1597-1604. (doi:10.1056/NEJMoa1105816)
104. Trevaskis J, Parkes D & Roth J 2010 Insights into amylin-leptin synergy. Trends in Endocrinology and Metabolism 21 473-479. (doi:10.1016/j.tem.2010.03.006)
105. Villanueva E & Myers M Jr 2008 Leptin receptor signaling and the regulation ofmammalian physiology. International Journal of Obesity 32 S8-12. (doi:10.1038/ijo.2008.232)
106. Wadden T, Neiberg R, Wing R, Clark J, Delahanty L, Hill J, Krakoff J, Otto A, Ryan D, Vitolins M et al. 2011 Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity 19 1987-1998. (doi:10.1038/oby.2011.230)
107. Welle S, Amatruda J, Forbes G & Lockwood D 1984 Resting metabolic rates of obese women after rapid weight loss. Journal of Clinical Endocrinology and Metabolism 59 41-44. (doi:10.1210/jcem-59-1-41)
108. Westerterp-Plantenga M, Saris W, Hukshorn C & Campfield L 2001 Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. American Journal of Clinical Nutrition 74 426-434.
109. Weyer C, Walford R, Harper I, Milner M, MacCallum T, Tataranni P & Ravussin E 2000 Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment. American Journal of Clinical Nutrition 72 946-953.
110. Wing R & Hill J 2001 Successful weight loss maintenance. Annual Review of Nutrition 21 323-341. (doi:10.1146/annurev.nutr.21.1.323)
111. Wing R & Phelan S 2005 Long-term weight maintenance. American Journal of Clinical Nutrition 82 222S-225S.
112. Yura S, Ogawa Y, Sagawa N, Masuzaki H, Itoh H, Ebihara K, Aizawa-Abe M, Fujii S & Nakao K 2000 Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin. Journal of Clinical Investigation 105 749-755. (doi:10.1172/JCI8353)
113. Zelissen P, Stenlof K, Lean M, Fogteloo J, Keulen E, Wilding J, Finer N, Rossner S, Lawrence E, Fletcher C et al. 2005 Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes, Obesity & Metabolism 7 755-761. (doi:10.1111/j.1463-1326.2005.00468.x)
114. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman J 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432. (doi:10.1038/372425a0)